Valuation: Enimmune corporation

Market Cap 1.15B 36.02M 30.84M 28.78M 26.4M 49.61M 3.45B 50.59M 341M 133M 1.73B 135M 132M 5.72B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.1B 34.31M 29.38M 27.41M 25.15M 47.26M 3.28B 48.19M 325M 127M 1.65B 129M 126M 5.45B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
28.72%
Yield 2024 *
-
Yield 2025 -
1 day-2.15%
1 week-5.34%
Current month+2.24%
1 month-1.54%
3 months-14.25%
6 months-20.05%
Current year-22.57%
1 week 15.8
Extreme 15.8
16.9
1 month 14.9
Extreme 14.9
17.1
Current year 14.9
Extreme 14.9
22.15
1 year 14.9
Extreme 14.9
23.9
3 years 14.65
Extreme 14.65
49.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 06/01/2019
Chief Tech/Sci/R&D Officer - 20/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 06/01/2019
Director/Board Member - 01/01/2014
Director/Board Member - 18/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%-5.34%-4.49%-60.76% 36.87M
+2.38%+5.57%+86.02%+115.89% 72.21B
+0.87%+16.32%+58.35%+97.28% 63.98B
-4.27%-0.99%-3.38%+468.55% 28.53B
+3.63%+8.62%+66.69%+23.95% 25.07B
-1.97%+20.38%-0.37%-5.65% 28.42B
-0.51%+5.11%+41.27%-12.79% 20.04B
-1.79%-4.51%+241.26%+414.48% 18.19B
+1.81%+0.85%+16.89%+546.06% 15.96B
-1.29%+6.09%+41.81%+151.24% 13.48B
Average -0.33%+4.82%+54.41%+173.82% 28.59B
Weighted average by Cap. +0.38%+7.47%+61.41%+162.42%

Financials

2024 2025
Net sales 39.92M 1.25M 1.07M 998K 916K 1.72M 120M 1.76M 11.84M 4.62M 59.92M 4.69M 4.59M 198M 48.19M 1.51M 1.29M 1.21M 1.11M 2.08M 144M 2.12M 14.3M 5.57M 72.35M 5.67M 5.54M 240M
Net income -158M -4.93M -4.22M -3.94M -3.62M -6.79M -472M -6.93M -46.74M -18.22M -237M -18.52M -18.12M -783M -164M -5.15M -4.41M -4.11M -3.77M -7.09M -492M -7.23M -48.76M -19.01M -247M -19.32M -18.9M -817M
Net Debt -382M -11.96M -10.24M -9.55M -8.77M -16.47M -1.14B -16.8M -113M -44.18M -574M -44.91M -43.93M -1.9B -54.59M -1.71M -1.46M -1.37M -1.25M -2.35M -164M -2.4M -16.2M -6.31M -81.96M -6.42M -6.28M -271M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
19/08/26 NT$15.95 -2.15% 60,503
19/08/26 NT$16.30 -0.91% 35,811
18/08/26 NT$16.45 +2.81% 15,152
17/08/26 NT$16.00 -2.14% 95,948
14/08/26 NT$16.35 -0.30% 103,159
  1. Stock Market
  2. Stocks
  3. 6564 Stock